United States Pharmaceuticals

Hims & Hers Health Inc (HIMS)

Track

Over the past 90 days, Hims & Hers Health Inc. saw 17 insider transactions, characterized by a net selling trend totaling approximately $7.69 million against $1.17 million in buys. Key executives, including the CFO and CTO, executed multiple planned sales. These activities follow the company's May 2026 results financiers, which reported an EPS miss.
Ticker: HIMS Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Hims & Hers Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 22 Jul 2026
Value US$2,229,504.68 | Price 16.92 | Shares 42,806
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2026-07-22 PrS Proposed sale
2.1
Pendarvis Christiane

Former Director

Non-Executive Director
42,806
16.92
US$2,229,505 		42,806 16.92 US$2,229,505
2026-07-20 2026-07-17 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
78,096 -0.1%
174.57
US$666,065 		78,096 -0.1% 174.57 US$666,065
2026-07-07 2026-07-06 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
75,534 -14.7%
118.49
US$791,747 		75,534 -14.7% 118.49 US$791,747
2026-07-06 2026-07-06 PrS Proposed sale
3.3
Oluyemi Okupe

Officer

Officer
28,652
38.28
US$1,096,799 		28,652 38.28 US$1,096,799
2026-06-23 2026-06-22 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
18,197 -6.0%
34.03
US$619,217 		18,197 -6.0% 34.03 US$619,217
2026-06-23 2026-06-18 S Sale
3.6
Carroll Patrick Harrison

Chief Medical Officer

Officer
23,726 -11.5%
35.00
US$830,410 		23,726 -11.5% 35.00 US$830,410
2026-06-18 2026-06-18 PrS Proposed sale
3.6
Carroll Patrick Harrison

Officer

Officer
23,726
35.00
US$830,410 		23,726 35.00 US$830,410
2026-06-17 2026-06-17 PlS Planned sale
2.4
Becklund Irene

PAO

Officer
4,490 -39.8%
31.50
US$141,435 		4,490 -39.8% 31.50 US$141,435
2026-06-17 2026-06-17 PlS Planned sale
0.5
Chi Michael

Chief Operating Officer

Officer
14,027 -3.1%
31.50
US$441,850 		14,027 -3.1% 31.50 US$441,850
2026-06-17 2026-06-17 PlS Planned sale
Elshenawy Mohamed

CTO

Officer
30,040 -22.9%
31.50
US$946,260 		30,040 -22.9% 31.50 US$946,260
2026-06-17 2026-06-17 PrS Proposed sale
2.4
Becklund Irene

Officer

Officer
4,490
31.50
US$141,435 		4,490 31.50 US$141,435
2026-06-17 2026-06-17 PrS Proposed sale
Elshenawy Mohamed

Officer

Officer
30,040
31.50
US$946,260 		30,040 31.50 US$946,260
2026-06-17 2026-06-17 PrS Proposed sale
0.5
Chi Michael

Officer

Officer
14,027
31.50
US$441,850 		14,027 31.50 US$441,850
2026-06-17 2026-06-16 PlS Planned sale
2.4
Becklund Irene

PAO

Officer
7,573 -40.2%
30.25
US$229,083 		7,573 -40.2% 30.25 US$229,083
2026-06-16 2026-06-16 PrS Proposed sale
2.4
Becklund Irene

Officer

Officer
7,573
30.25
US$229,083 		7,573 30.25 US$229,083
2026-05-26 2026-05-26 B Purchase
2.7
WELLS DAVID B
Non-Executive Director
48,400 +27.5%
24.24
US$1,172,974 		48,400 +27.5% 24.24 US$1,172,974
2026-05-19 2026-05-18 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
7,950 -2.9%
23.64
US$187,916 		7,950 -2.9% 23.64 US$187,916
2026-04-22 2026-04-20 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
9,463 -3.1%
30.00
US$283,890 		9,463 -3.1% 30.00 US$283,890
2026-04-22 2026-04-20 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
19,645 -7.0%
29.96
US$588,615 		19,645 -7.0% 29.96 US$588,615
2026-04-20 2026-04-20 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
9,463
30.00
US$283,890 		9,463 30.00 US$283,890
2026-04-20 2026-04-17 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
18,005 -6.3%
27.83
US$501,158 		18,005 -6.3% 27.83 US$501,158
2026-04-20 2026-04-16 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
36,922 -11.6%
25.90
US$956,147 		36,922 -11.6% 25.90 US$956,147
2026-04-07 2026-04-06 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
3,975 -1.2%
19.98
US$79,409 		3,975 -1.2% 19.98 US$79,409
2026-04-06 2026-04-06 PrS Proposed sale
3.3
Oluyemi Okupe

Officer

Officer
240,560
20.33
US$4,890,585 		240,560 20.33 US$4,890,585
2026-03-24 2026-03-20 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
9,217 -2.8%
23.77
US$219,067 		9,217 -2.8% 23.77 US$219,067
2026-03-18 2026-03-17 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
4,812 -1.5%
24.69
US$118,808 		4,812 -1.5% 24.69 US$118,808
2026-03-18 2026-03-17 PlS Planned sale
2.4
Becklund Irene

PAO

Officer
5,529 -38.7%
24.69
US$136,511 		5,529 -38.7% 24.69 US$136,511
2026-03-18 2026-03-17 PlS Planned sale
0.5
Chi Michael

Chief Operating Officer

Officer
97,289 -19.3%
24.69
US$2,402,065 		97,289 -19.3% 24.69 US$2,402,065
2026-03-17 2026-03-17 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
4,812
24.69
US$118,808 		4,812 24.69 US$118,808
2026-03-17 2026-03-17 PrS Proposed sale
2.4
Becklund Irene

Officer

Officer
5,529
24.69
US$136,511 		5,529 24.69 US$136,511
2026-03-17 2026-03-17 PrS Proposed sale
0.5
Chi Michael

Officer

Officer
97,289
24.69
US$2,402,065 		97,289 24.69 US$2,402,065
2026-03-02 2026-02-27 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
4,651 -1.0%
15.21
US$70,742 		4,651 -1.0% 15.21 US$70,742
2026-02-27 2026-02-27 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
4,651
15.21
US$70,742 		4,651 15.21 US$70,742
2026-02-04 2026-02-03 S Sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
5,262 -5.4%
26.44
US$139,108 		5,262 -5.4% 26.44 US$139,108
2026-02-04 2026-02-03 S Sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
5,262 -5.4%
26.44
US$139,108 		5,262 -5.4% 26.44 US$139,108
2026-01-21 2026-01-20 S Sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
9,067 -9.0%
30.34
US$275,114 		9,067 -9.0% 30.34 US$275,114
2026-01-20 2026-01-20 PrS Proposed sale
3.3
Oluyemi Okupe

Officer

Officer
27,204
30.47
US$828,906 		27,204 30.47 US$828,906
2026-01-07 2026-01-05 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
9,070 -9.0%
33.79
US$306,453 		9,070 -9.0% 33.79 US$306,453
2025-12-23 2025-12-22 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
23,090 -19.7%
35.72
US$824,710 		23,090 -19.7% 35.72 US$824,710
2025-12-22 2025-12-22 PrS Proposed sale
3.3
Oluyemi Okupe

Officer

Officer
32,160
35.05
US$1,127,208 		32,160 35.05 US$1,127,208
2025-12-18 2025-12-17 PlS Planned sale
0.5
Chi Michael

Chief Operating Officer

Officer
13,750 -4.3%
36.71
US$504,762 		13,750 -4.3% 36.71 US$504,762
2025-12-18 2025-12-17 PlS Planned sale
3.6
Carroll Patrick Harrison

Chief Medical Officer

Executive Director
10,021 -5.6%
36.71
US$367,871 		10,021 -5.6% 36.71 US$367,871
2025-12-18 2025-12-17 PlS Planned sale
2.4
Becklund Irene

PAO

Officer
8,411 -79.8%
36.71
US$308,768 		8,411 -79.8% 36.71 US$308,768
2025-12-18 2025-12-17 PlS Planned sale
2.0
Autor Deborah M.

Chief Policy Officer

Executive Director
7,054 -53.3%
36.71
US$258,952 		7,054 -53.3% 36.71 US$258,952
2025-12-17 2025-12-17 PrS Proposed sale
3.6
Carroll Patrick Harrison

Officer; Director

Executive Director
10,021
36.71
US$367,871 		10,021 36.71 US$367,871
2025-12-17 2025-12-17 PrS Proposed sale
0.5
Chi Michael

Officer

Officer
13,750
36.71
US$504,762 		13,750 36.71 US$504,762
2025-12-17 2025-12-17 PrS Proposed sale
2.4
Becklund Irene

Officer

Officer
8,411
36.71
US$308,768 		8,411 36.71 US$308,768
2025-12-17 2025-12-17 PrS Proposed sale
2.0
Autor Deborah M.

Officer; Director

Executive Director
7,054
36.71
US$258,952 		7,054 36.71 US$258,952
2025-12-10 2025-12-09 S Sale
3.3
Perez Garcia Andrea G
Non-Executive Director
2,500 -3.0%
39.17
US$97,925 		2,500 -3.0% 39.17 US$97,925
2025-12-09 2025-12-09 PrS Proposed sale
3.3
Perez Garcia Andrea G

Director

Non-Executive Director
2,500
39.17
US$97,925 		2,500 39.17 US$97,925
2025-11-25 2025-11-24 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
2,631 -1.7%
35.22
US$92,664 		2,631 -1.7% 35.22 US$92,664
2025-11-24 2025-11-24 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
2,631
35.11
US$92,374 		2,631 35.11 US$92,374
2025-11-19 2025-11-17 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
23,187 -24.8%
36.81
US$853,490 		23,187 -24.8% 36.81 US$853,490
2025-11-12 2025-11-10 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
2,637 -1.7%
42.53
US$112,152 		2,637 -1.7% 42.53 US$112,152
2025-11-10 2025-11-10 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
2,637
42.53
US$112,152 		2,637 42.53 US$112,152
2025-10-28 2025-10-27 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
2,637 -1.6%
50.10
US$132,114 		2,637 -1.6% 50.10 US$132,114
2025-10-27 2025-10-27 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
2,637
50.10
US$132,114 		2,637 50.10 US$132,114
2025-10-20 2025-10-17 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
11,592 -14.2%
57.13
US$662,222 		11,592 -14.2% 57.13 US$662,222
2025-10-20 2025-10-16 PlS Planned sale
3.4
Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
16,667 -15.3%
62.70
US$1,044,969 		16,667 -15.3% 62.70 US$1,044,969
2025-10-20 2025-10-16 PlS Planned sale
3.4
Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
2,335 -2.1%
63.39
US$148,009 		2,335 -2.1% 63.39 US$148,009
2025-10-20 2025-10-16 PlS Planned sale
3.4
Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
39,332 -26.1%
62.70
US$2,466,112 		39,332 -26.1% 62.70 US$2,466,112
2025-10-20 2025-10-16 PlS Planned sale
3.4
Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
10,469 -6.5%
63.49
US$664,627 		10,469 -6.5% 63.49 US$664,627
2025-10-20 2025-10-16 PlS Planned sale
3.4
Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
39,531 -19.7%
62.71
US$2,478,803 		39,531 -19.7% 62.71 US$2,478,803
2025-10-20 2025-10-16 PlS Planned sale
3.4
Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
17,001 -15.5%
62.69
US$1,065,793 		17,001 -15.5% 62.69 US$1,065,793
2025-10-20 2025-10-16 PlS Planned sale
3.4
Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
8,423 -15.1%
63.46
US$534,513 		8,423 -15.1% 63.46 US$534,513
2025-10-20 2025-10-16 PlS Planned sale
3.4
Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
39,111 -41.1%
62.70
US$2,452,248 		39,111 -41.1% 62.70 US$2,452,248
2025-10-20 2025-10-16 PlS Planned sale
3.4
Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
2,792 -2.9%
62.65
US$174,924 		2,792 -2.9% 62.65 US$174,924
2025-10-16 2025-10-16 PrS Proposed sale
3.4
Dudum Andrew

Officer; Director

Executive Director
175,661
62.79
US$11,029,998 		175,661 62.79 US$11,029,998
2025-10-14 2025-10-13 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
2,637
54.38
US$143,400 		2,637 54.38 US$143,400
2025-10-14 2025-10-13 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
2,637 -1.6%
54.38
US$143,400 		2,637 -1.6% 54.38 US$143,400
2025-10-14 2025-10-10 PlS Planned sale
0.5
Chi Michael

Chief Commercial Officer

Officer
900 -0.3%
58.25
US$52,425 		900 -0.3% 58.25 US$52,425
2025-10-10 2025-10-10 PrS Proposed sale
0.5
Chi Michael

Officer

Officer
900
58.25
US$52,425 		900 58.25 US$52,425
2025-10-07 2025-10-03 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
11,595 -14.2%
57.72
US$669,232 		11,595 -14.2% 57.72 US$669,232
2025-10-02 2025-10-01 PlS Planned sale
0.5
Chi Michael

Chief Commercial Officer

Officer
250 -0.1%
56.00
US$14,000 		250 -0.1% 56.00 US$14,000
2025-10-01 2025-10-01 PrS Proposed sale
0.5
Chi Michael

Officer

Officer
250
56.00
US$14,000 		250 56.00 US$14,000
Explore more

More insider trading research around Hims & Hers Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America